1213 ET - Life Time Group is set to benefit from a wave of consumers wanting healthier lifestyles, UBS analysts say in a research note. "We see more affluent baby boomers incorporating more movement into their day to day life and we see Gen Zs as a much more fitness minded demographic that will further support demand for higher end wellness offering," the analysts say. With GLP-1 drugs gaining popularity, the analysts see another tailwind for Life Time and the fitness industry. The analysts anticipate a growing urgency for cardio and strength exercise to prevent loss of muscle mass and bone density in a growing number of GLP-1 patients. Life Time Group shares fall 2.1%. (amira.mckee@wsj.com)
(END) Dow Jones Newswires
March 12, 2026 12:14 ET (16:14 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments